Aptevo Therapeutics Stock (NASDAQ:APVO), Quotes and News Summary

Q: What sector and industry does Aptevo Therapeutics (APVO) operate in?

Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Aptevo Therapeutics Stock (NASDAQ: APVO) stock price, news, charts, stock research, profile.

Open	$0.940
Close	$0.890
Volume / Avg.	188.546K / 866.503K
Day Range	0.880 - 0.965
52 Wk Range	0.670 - 80.960
Market Cap	$3.227M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	4.06%
Days to Cover	1

Recent News

Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Nasdaq Jumps 250 Points; Crude Oil Down 1%

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433.83. The S&P 500 also rose, gaining, 0.83% to 5,203.26.

Avi Kapoor

Why Aptevo Therapeutics Stock Is Cratering

Aptevo announced the pricing of a public offering of 3,400,000 shares of its common stock or pre-funded warrants in lieu thereof and warrants to purchase up to an aggregate of 6,800,000 shares of its common stock at a purchase price of $1.35 per share.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aptevo Therapeutics (APVO) stock?

You can purchase shares of Aptevo Therapeutics (NASDAQ: APVO) through any online brokerage.

View our list of the best stock brokerages.

Who are Aptevo Therapeutics's (APVO) competitors?

Other companies in Aptevo Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Geovax Labs (NASDAQ:GOVX).

What is the target price for Aptevo Therapeutics (APVO) stock?

The latest price target for Aptevo Therapeutics (NASDAQ: APVO) was reported by Piper Sandler on Friday, May 13, 2022. The analyst firm set a price target for 20.00 expecting APVO to rise to within 12 months (a possible 2127.17% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Aptevo Therapeutics (APVO)?

The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $0.898 last updated May 10, 2024 at 7:57 PM EDT.

Does Aptevo Therapeutics (APVO) pay a dividend?

There are no upcoming dividends for Aptevo Therapeutics.

When is Aptevo Therapeutics (NASDAQ:APVO) reporting earnings?

Aptevo Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is Aptevo Therapeutics (APVO) going to split?

There is no upcoming split for Aptevo Therapeutics.

What sector and industry does Aptevo Therapeutics (APVO) operate in?

Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-